Efficacy and Safety of CRC01 in Participants With Severe, Refractory Systemic Lupus Erythematosus
Efficacy and Safety of CRC01 in Participants With Severe, Refractory Systemic Lupus Erythematosus
Not yet recruiting · NCT07364396 · Registry updated 2026-01-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of CRC01 in Participants With Severe, Refractory Systemic Lupus Erythematosus | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, nephritis, systemic lupus erythematosus, urinary system disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-01-23 | NCT07364396 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Curocell Inc. | 2 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||